Non-melanoma Skin Cancer Clinical Trial
Official title:
Near-infrared Heating of Skin to Delineate Non-melanoma Skin Cancer Lesions: a Pilot Study.
We aim to determine whether the application of near-infrared radiation via standard heat lamp to non-melanoma skin lesions (such as basal cell carcinomas) before surgical excision is able to better delineate the lesion and surgical margins. If found to do so, pre-heating of skin lesions could lead to more specimens with negative margins. Patients presenting to the tertiary care centre skin cancer clinic for excision of skin cancer will be approached and offered to participate in the study.
Non-melanoma skin cancer (NMSC) is the most common cancer diagnosis in Canada, and its
incidence is still increasing. Visual examination followed by biopsies of suspicious lesions
are the gold standard for skin cancer diagnosis. The mainstays of treatment include
photodynamic therapy, radiation therapy, and surgical excision. The margins of NMSC lesions
are typically determined via visual inspection, and excised based on delineating normal from
abnormal tissue. According to the National Comprehensive Cancer Network, low-risk basal cell
cancers should be excised with a 4mm margin; squamous cell skin cancers and high-risk basal
cell cancers should be excised with 4-6mm margins, as per the National Comprehensive Cancer
Network. These lesions frequently occur on cosmetically sensitive areas of the head and neck,
therefore accurate margins and excision can help to preserve the overall appearance. Accurate
lesion delineation with proper margins can also reduce the need for further treatment if the
margins are positive. In approximately 2-3% of cases at our centre, the margins are positive.
Near-infrared radiation (NIR) represents the light spectrum from 0.7 to 1.5 micrometers. At
the shorter wavelengths, it merges with the red spectrum of visible light. These forms of
light have the ability to heat the skin up to a 5 mm depth. Previous studies have examined
the relationship between skin blood flow and temperature when heating skin, where dermal
temperature can reach a certain peak in a defined time. Other studies have investigated the
application of NIR when combined with photo immunotherapy, as a means of treating other
cancers. More elaborate multispectral analysis devices have been studied for their
effectiveness in diagnosing cutaneous malignancies. NIR application is well tolerated, in
past studies.The objective of this study is to determine if the vasculature of normal skin
and NMSC skin appears differently following heating with NIR light, and if this difference
corresponds to better margin delineation.
The excisions and reconstructions are all within the standard of care. The only added testing
will be application of near-infrared heat via a heating lamp to the lesional skin, for a
total of ten minutes. Each patient will have their skin cancer lesion photographed, and
traced onto acetate film. The NIR heating will then occur under a lamp for a total of ten
minutes at a distance of 20cm. At the end of the ten minutes, the lesion and its borders will
again be traced onto a separate acetate film. Using Excel for block randomization, patients
will then be randomized to excision with the non-heated versus heated margins. The allocation
will not be known until the moment of assignment. The excisions will then occur in the same
fashion between the two groups, and all specimens will be submitted for pathology, as is
standard of care.
Data will be recorded for various patient and lesions factors that may potentially influence
the outcome of NIR heating therapy. These include age and gender, lesion size and location,
and history of skin disorders. The lesion size and final pathology, with quantitative margin
distances, will be recorded. Statistical analysis will be performed to determine if there is
an overall difference in qualitative (negative or positive) and quantitative margin status
between those lesions excised under standard procedure vs. NIR heating.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01053819 -
Can We Miss Pigmented Lesions in Psoriasis Patients?
|
Phase 4 | |
Recruiting |
NCT03767348 -
Study of RP1 Monotherapy and RP1 in Combination With Nivolumab
|
Phase 2 | |
Recruiting |
NCT05429866 -
Immunological Variables Associated to ICI Toxicity in Cancer Patients
|
Phase 2 | |
Active, not recruiting |
NCT02636569 -
Topical Chemoprevention of Skin Cancer Biomarkers
|
Phase 2 | |
Completed |
NCT02760160 -
Dietary Prevention of Photodamage in Skin With Grapes
|
N/A | |
Completed |
NCT02780934 -
Comparing Pressure Versus Simple Adhesive Dressing After Mohs Reconstruction
|
N/A | |
Completed |
NCT02872909 -
Randomized Comparison of Low and Conventional Irradiance PDT for Skin Cancer
|
N/A | |
Withdrawn |
NCT03327064 -
A Biomarker Evaluation Trial of UAB30 in Renal Transplant Recipients at High Risk for Non-melanoma Skin Cancer
|
Phase 1/Phase 2 | |
Completed |
NCT00342407 -
The Incidence of Breast and Other Cancers Among Female Flight Attendants
|
||
Terminated |
NCT04410874 -
Imvamune Vaccine for the Treatment of Non-melanoma Skin Cancer
|
Phase 1/Phase 2 | |
Completed |
NCT03693937 -
A Retrospective Evaluation of Superficial Radiation Therapy (SRT) and Non-Melanoma Skin Cancer (NMSC)
|
||
Completed |
NCT04334824 -
Hydrochlorothiazide and Risk of Skin Cancer
|
||
Recruiting |
NCT05878288 -
Deep sequencIng in Cutaneous Squamous CEll caRciNomas
|
Phase 2 | |
Completed |
NCT01359735 -
Healing Effects of HP802-247 Versus Antibiotic Ointment in Mohs Micrographic Surgery Patients
|
Phase 2 | |
Terminated |
NCT04348916 -
Study of ONCR-177 Alone and in Combination With PD-1 Blockade in Adult Subjects With Advanced and/or Refractory Cutaneous, Subcutaneous or Metastatic Nodal Solid Tumors or With Liver Metastases of Solid Tumors
|
Phase 1 | |
Enrolling by invitation |
NCT05257486 -
Post-market Multi-Center RETRO-Prospective Study to Assess Long-term Clinical Outcomes NMSC Patients Treated With eBx
|
||
Recruiting |
NCT06428721 -
The Preventive Role of Fractionated Laser Resurfacing Against Actinic Neoplasia in an At-Risk Geriatric Population
|
N/A | |
Withdrawn |
NCT03757663 -
UV Dosimetry Feedback in NMSC Patients
|
N/A | |
Completed |
NCT04116983 -
DERM NMSC Validation Study
|
||
Active, not recruiting |
NCT06227416 -
Skin Tumor Biomarkers by Mass Spectrometry Imaging
|
N/A |